Albany, NY -- (SBWIRE) -- 11/05/2014 -- Hospital acquired bacterial infections (HABI) or nosocomial infections are type of infections commonly caused by bacterial pathogens and are acquired in healthcare facilities or hospitals. These pathogens should be examined in all patients who have developed some kind of clinical deterioration unexplained during the initial diagnosis. Currently, HABI market is a lucrative market venture due to increasing incidence rate of hospital acquired infections, which makes this industry a highly profitable and attractive market.

Browse Full Hospital Acquired Bacterial Infections Market Report
http://www.transparencymarketresearch.com/hospital-acquired-bacterial-infections.html

Some of the type of techniques and methods usually opted for performing various test for the diagnosis of hospital acquired bacterial infections are as follows:

DNA Sequencing
Colorimetric Methods
Microarrays
RT-PCR
Solid-phase Hybridization Techniques
Phage-based Assays
The Nitrate Reductase Assay
Phenotypic Methods

The following are the types of hospital acquired bacterial infections:

Urinary Tract Infections (UTI)
Pneumonia
Blood Stream Infections (BSI)
Surgical Site Infections

Some of the anti bacterial drug classes generally used for the treatment of HABI are as follows:

Aminoglycosides
B-Lactam Antibiotics
Lincosamides
Glycopeptides
Carbapenems
Macrolides
Lipopeptides
Polypeptides
Quinolones
Penicillins
Sulfonamides
Tetracyclines

In the geographical analysis, North America is the leading market for hospital acquired bacterial infections treatment and testing market. Due to stringent hospital regulatory policies and increased government initiatives to prevent and control various hospital-acquired infections, this region is able to maintain its dominant position across the world. Europe closely follows North America is terms of growth, due to increasing incidence of hospital-acquired infections. According to the Health Protection Agency (HPA) approximately of patients in hospitals in England acquire some form of bacterial infection during their hospital stay. However, other regions such as South East Asia, Middle East and Latin America are expected to be the promising markets in the near future. Owing to the rising disposable income among population, increasing incidence of bacterial infections and developing healthcare infrastructure, these regions are expected to be the potential market in the near future.

Browse More Report on Pharmaceuticals Market
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Some of the major factors propelling the growth of Hospital Acquired Bacterial Infections (HABI) market are increasing incidence rate of hospital acquired bacterial infections and introduction of novel therapeutics that are safe and highly effective. Moreover, development of personalized medicines designed specifically according to the genetic composition of an individual is also expected to drive this market to a certain extent. It is also expected that introduction of innovative infection control devices and products, that are cost-effective would help in the market size expansion of the overall HABI market. However, patent expiries of antibacterial drugs such as Invanz, Levaquin, Zyvox and Tobi are expected to erode the hospital acquired bacterial infections market.

Additionally, market-restraining factors that could hamper the growth of the market are increased hygiene surveillance in hospitals and healthcare facilities along with resistance developed against antibacterials, which makes existing antibacterial drugs archaic in some circumstances. However, concerns focusing on product safety and effectiveness along with availability of these products are some of the factors that considerably affect the sales and growth of the hospital acquired bacterial infections market.

Currently, the hospital acquired bacterial infections market is a highly fragmented market due to the involvement of many established and emerging players. Some of the key players involved in the Hospital Acquired Bacterial Infections (HABI) market are Abbott Laboratories, AstraZeneca plc, Bayer Schering Pharma AG, Becton, Dickinson and Company, Cepheid, Inc., Cubist Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Kimberly-Clark Corporation, Pfizer, Inc. and Tetraphase Pharmaceuticals, Inc.

Enquiry Before Buying
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2910

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Geographies analyzed under this research report include:

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of:

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry

players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Latest Upcoming Reports:
http://www.transparencymarketresearch.com/upcoming.htm

About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Latest Upcoming Reports:
http://www.transparencymarketresearch.com/upcoming.htm

Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse market research blog:
http://www.tmrblog.com/